Avviso di rettifica
Errata corrige
Errata corrige
Modifica secondaria di un'autorizzazione all'immissione in commercio di specialita' medicinale per uso umano. Modifica apportata ai sensi D.Lgs. 274/07. Titolare A.I.C.: B. Braun Melsungen AG, Melsungen (Germania) Codice pratica: C1A/2011/744. Specialita' medicinale, confezione e n. di A.I.C.: Amixal 10%, tutte le confezioni e relativi numeri di A.I.C. Modifica apportata ai sensi del regolamento CE 1234/2008. Procedura n.: DE/H/0543/IA/006/G - Grouping variation (Annual Report). B.III.1.a).1: Submission of a new or updated Ph. Eur. certificate of suitability: - For an active substance; - For a starting material/reagent/intermediate used in the manufacturing process of the active substance;- For an excipient. a) Europ. Pharmacopoieal CEP to the relevant Ph.Eur.Monograph. 1) New certificate from an already approved manufacturer. New Certificate n. R0-CEP 2005-060-Rev 00 for Lysine Acetate by Ajinomoto Co., Inc., JP 104-8315 Tokyo. B.III.1.a).2: Submission of a new or updated Ph. Eur. certificate of suitability: - For an active substance; - For a starting material/reagent/intermediate used in the manufacturing process of the active substance;- For an excipient. a) Europ. Pharmacopoieal CEP to the relevant Ph.Eur.Monograph. 2) Updated certificate from an already approved manufacturer. Updated Certificate n. R1-CEP 1999-013-Rev 01 for Alanine by KYOWA HAKKO BIO Co., Ltd., JP 100-8185 Tokyo. Updated Certificate n. R1-CEP 1998-104-Rev 02 for Arginine by Ajinomoto Co., Inc., JP 104-8315 Tokyo. Updated Certificate n. R1-CEP 1998-109-Rev 02 for Arginine by KYOWA HAKKO BIO Co., Ltd., JP 100-8185 Tokyo. Updated Certificate n. R1-CEP 2003-143-Rev 02 for Aspartic Acid by Ajinomoto Co., Inc., JP 104-8315 Tokyo. Updated Certificate n. R1-CEP 1999-190-Rev 01 for Aspartic Acid by KYOWA HAKKO BIO Co., Ltd., JP 100-8185 Tokyo. Updated Certificate n. R1-CEP 1998-107-Rev 01 for Histidine by Ajinomoto Co., Inc., JP 104-8315 Tokyo. Updated Certificate n. R1-CEP 1999-027-Rev 02 for Histidine by KYOWA HAKKO BIO Co., Ltd., JP 100-8185 Tokyo. Updated Certificate n. R0-CEP 2004-228-Rev 02 for Isoleucine by AMINO GmbH, DE 38373 Frellstedt. Updated Certificate n. R1-CEP 1999-014-Rev 02 for Isoleucine by KYOWA HAKKO BIO Co., Ltd., JP 100-8185 Tokyo. Updated Certificate n. R1-CEP 1999-160-Rev 02 for Leucine by KYOWA HAKKO BIO Co., Ltd., JP 100-8185 Tokyo. Updated Certificate n. R0-CEP 2005-190-Rev 01 for Methionine by EVONIK REXIM (NANNING) PHARMACEUTICAL Co., Ltd., CN 530 100 Nanning City. Updated Certificate n. R1-CEP 1998-067-Rev 01 for Phenylalanine by Ajinomoto Co., Inc., JP 104-8315 Tokyo. Updated Certificate n. R1-CEP 1999-084-Rev 02 for Phenylalanine by KYOWA HAKKO BIO Co., Lttd., JP 100-8185 Tokyo. Updated Certificate n. R0-CEP 2007-166-Rev 00 for Phenylalanine by EVONIK REXIM S.A.S, FR 80400 Ham. Updated Certificate n. R1-CEP 1999-018-Rev 01 for Proline by KYOWA HAKKO BIO Co., Ltd., JP 100-8185 Tokyo. Updated Certificate n. R1-CEP 1999-019-Rev 01 for Serine by KYOWA HAKKO BIO Co., Ltd., JP 100-8185 Tokyo. Updated Certificate n. R0-CEP 2004-277-Rev 02 for Threonine by AMINO GmbH, DE 38373 Frellstedt. Updated Certificate n. R1-CEP 1999-015-Rev 01 for Threonine by KYOWA HAKKO BIO Co., Ltd., JP 100-8185 Tokyo. Updated Certificate n. R1-CEP 1998-137-Rev 01 for Tryptophan by Ajinomoto Co., Inc., JP 104-8315 Tokyo. Updated Certificate n. R1-CEP 1999-050-Rev 04 for Tryptophan by AMINO GmbH, DE 38373 Frellstedt. Updated Certificate n. R1-CEP 1999-189-Rev 01 for Tryptophan by KYOWA HAKKO BIO Co., Ltd., JP 100-8185 Tokyo. Updated Certificate n. R1-CEP 1998-034-Rev 01 for Tyrosine by AMINO GmbH, DE 38373 Frellstedt. Updated Certificate n. R1-CEP 1998-106-Rev 03 for Valine by Ajinomoto Co., Inc., JP 104-8315 Tokyo. Updated Certificate n. R1-CEP 1999-016-Rev 01 for Valine by KYOWA HAKKO BIO Co., Ltd., JP 100-8185 Tokyo. B.III.1.a).3: Submission of a new or updated Ph. Eur. certificate of suitability: For an active substance; For a starting material/reagent/intermediate used in the manufacturing process of the active substance;- For an excipient. a) Europ. Pharmacopoieal CEP to the relevant Ph.Eur.Monograph. 3) New certificate from a new manufacturer (replacement or addition). Addition of EVONIK REXIM (NANNING) PHARMACEUTICAL Co., Ltd., CN 530 100 Nanning City, as manufacturer for Glycine with CEP n. R0-CEP 2008-099-Rev 00. Addition of EVONIK REXIM (NANNING) PHARMACEUTICAL Co., Ltd., CN 530 100 Nanning City, as manufacturer for Isoleucine with CEP n. R0-CEP 2008-098-Rev 00 I lotti gia' prodotti sono mantenuti in commercio fino alla data di scadenza indicata in etichetta ai sensi art.14 D.L.vo 178/91 e s.m.i. Decorrenza della modifica: dal giorno successivo alla data della sua pubblicazione in G.U. L'amministratore delegato dott. Luigi Boggio T11ADD9422